|
Secondary prevention
Citations 351-360 of 566 total displayed.
|
Past content
(since Feb 1999):
|
- Articles
Physical Activity in Relation to Cardiovascular Disease and Total Mortality Among Men With Type 2 Diabetes
- Mihaela Tanasescu, Michael F. Leitzmann, Eric B. Rimm, and Frank B. Hu
Circulation published April 28, 2003, doi:10.1161/01.CIR.0000066906.11109.1F
[Abstract]
- Clinical Cardiology: New Frontiers
Prevention of Cardiovascular Ischemic Events: High-Risk and Secondary Prevention
- Jacques Genest and Terje R. Pedersen
Circulation 2003;107:2059-2065, doi:10.1161/01.CIR.0000067881.26274.BD
[Full text]
- Articles
Improved Exercise Tolerance and Quality of Life With Cardiac Rehabilitation of Older Patients After Myocardial Infarction. Results of a Randomized, Controlled Trial
- Niccolò Marchionni, Francesco Fattirolli, Stefano Fumagalli, Neil Oldridge, Francesco Del Lungo, Linda Morosi, Costanza Burgisser, and Giulio Masotti
Circulation published April 21, 2003, doi:10.1161/01.CIR.0000066322.21016.4A
[Abstract]
- Clinical Investigations and Reports
Relation of Inflammation and Benefit of Statins After Percutaneous Coronary Interventions
- Albert W. Chan, Deepak L. Bhatt, Derek P. Chew, Joel Reginelli, Jakob P. Schneider, Eric J. Topol, and Stephen G. Ellis
Circulation 2003;107:1750-1756; published online before print as doi:10.1161/01.CIR.0000060541.18923.E9
[Abstract]
[Full text]
- AHA/ACC Conference Proceedings
Challenges and Opportunities in Quantifying the Quality of Care for Acute Myocardial Infarction: Summary From the Acute Myocardial Infarction Working Group of the American Heart Association/American College of Cardiology First Scientific Forum on Quality of Care and Outcomes Research in Cardiovascular Disease and Stroke
- John A. Spertus, Martha J. Radford, Nathan R. Every, Edward F. Ellerbeck, Eric D. Peterson, and Harlan M. Krumholz
Circulation 2003;107:1681-1691, doi:10.1161/01.CIR.0000062026.90014.63
[Full text]
- Articles
Relation of Inflammation and Benefit of Statins After Percutaneous Coronary Interventions
- Albert W. Chan, Deepak L. Bhatt, Derek P. Chew, Joel Reginelli, Jakob P. Schneider, Eric J. Topol, and Stephen G. Ellis
Circulation published March 24, 2003, doi:10.1161/01.CIR.0000060541.18923.E9
[Abstract]
- Editorials
Antibiotic Treatment of Atherosclerotic Cardiovascular Disease
- J. Thomas Grayston
Circulation 2003;107:1228-1230, doi:10.1161/01.CIR.0000056032.56396.89
[Full text]
- Editorials
Drug Therapy and Heart Failure Prevention
- Jennifer V. Linseman and Michael R. Bristow
Circulation 2003;107:1234-1236, doi:10.1161/01.CIR.0000056033.16159.48
[Full text]
- Clinical Investigations and Reports
Antibiotic Therapy After Acute Myocardial Infarction: A Prospective Randomized Study
- Ralf Zahn, Steffen Schneider, Birgit Frilling, Karlheinz Seidl, Ulrich Tebbe, Michael Weber, Martin Gottwik, Ernst Altmann, Friedrich Seidel, Jürgen Rox, Ulrich Höffler, Karl-Ludwig Neuhaus, Jochen Senges for the Arbeitsgemeinschaft Leitender Kardiologischer Krankenhausärzte (Working Group of Leading Hospital Cardiologists; ALKK)
Circulation 2003;107:1253-1259; published online before print as doi:10.1161/01.CIR.0000054613.57105.06
[Abstract]
[Full text]
- Clinical Investigations and Reports
Prevention of Heart Failure in Patients in the Heart Outcomes Prevention Evaluation (HOPE) Study
- J. Malcolm O. Arnold, Salim Yusuf, James Young, James Mathew, David Johnstone, Alvaro Avezum, Eva Lonn, Janice Pogue, Jackie Bosch on behalf of the HOPE Investigators
Circulation 2003;107:1284-1290; published online before print as doi:10.1161/01.CIR.0000054165.93055.42
[Abstract]
[Full text]
|
|
